Norethindrone enanthate

Norethindrone enanthate
IUPAC name [(9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] heptanoate
Identifiers
CAS number	3836-23-5
PubChem	19688
Beilstein Reference	3176529
Jmol-3D images	Image 1
SMILES CCCCCCC(=O)O[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3C2CCC4=CC(=O)CC[C@H]34)C)C#C
Properties
Molecular formula	C27H38O3
Molar mass	410.59 g mol−1
Y (verify) (what is: Y/N?) Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa)
Infobox references

Norethindrone enanthate is a derivative of norethindrone, a synthetic progestogen.

Antiprogestin/
SPRM

antagonist: Mifepristone

Asoprisnil • CDB-4124  • Ulipristal acetate

Estrogens

Agonist	Steroidal Diosgenin • Estradiol (Ethinylestradiol#/Mestranol • Estradiol 17 beta-cypionate# • Polyestradiol phosphate) • Estrone (Estrone sulfate) • Estriol • Promestriene • Equilenin • Equilin Nonsteroidal Chlorotrianisene • Dienestrol • Fosfestrol • Diethylstilbestrol • Zeranol
Antiestrogen/ SERM	Afimoxifene • Arzoxifene • Bazedoxifene • Cyclofenil • Lasofoxifene • Ormeloxifene • Raloxifene • Tamoxifen • Toremifene Clomifene# • Mepitiostane • Nafoxidine pure antagonist: Fulvestrant
Aromatase inhibitors	nonselective: Aminoglutethimide • Testolactone selective: Anastrozole • Atamestane • Exemestane • Fadrozole • Formestane • Letrozole • Vorozole

^#WHO-EM. ^‡Withdrawn from market. Clinical trials: ^†Phase III. ^§Never to phase III

M: ♀ FRS anat/phys/devp noco/cong/npls, sysi/epon proc/asst, drug (G1/G2B/G3CD)